The prognostic value of inflammation-based scores in advanced hepatocellular carcinoma patients prior to treatment with sorafenib.
Oncotarget
; 8(56): 95853-95864, 2017 Nov 10.
Article
in En
| MEDLINE
| ID: mdl-29221172
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Oncotarget
Year:
2017
Document type:
Article
Affiliation country:
France
Country of publication:
United States